Carmelo P.
- Country
- Italy
- Department
- medical oncology
Research Overview
- Phase 3 Randomized, Double-Blind Study of Bemarituzumab with mFOLFOX6 in FGFR2b-Overexpressing Advanced Gastric or Gastroesophageal Junction Cancer
- Comparison of Ramucirumab with Irinotecan, Leucovorin, and 5-FU Versus Ramucirumab with Paclitaxel in Advanced or Metastatic Gastric Adenocarcinoma
- Phase 3 Randomized Study of Zolbetuximab, Pembrolizumab, and Chemotherapy in HER2-Negative, CLDN18.2-Positive, PD-L1-Positive Gastric Adenocarcinoma
Data & Insights
Has run more than one trial at 35 of 225 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating advanced gastric cancer and gastroesophageal junction adenocarcinoma, with particular focus on developing therapeutic strategies for patients with advanced or metastatic disease.
- Advanced Gastric Cancer Treatment
- Gastroesophageal Junction Tumors
- Metastatic Adenocarcinoma Management
Their expertise extends to evaluating novel targeted therapies for gastrointestinal malignancies.
Targeted Therapy Development
The investigator focuses on innovative approaches in targeted therapeutic agents, particularly exploring the potential of FGFR2b-targeted treatments and combination therapies in gastrointestinal cancers.
- Molecular Targeted Therapies
- Biomarker-Driven Treatment
- Combination Treatment Strategies
Their work encompasses evaluation of novel therapeutic combinations for enhanced treatment outcomes.
Treatment Resistance
The investigator studies therapeutic approaches for patients with treatment-resistant gastric cancer, specifically focusing on developing effective second-line treatment strategies after initial therapy failure.
- Second-line Therapy Development
- Treatment Response Assessment
- Survival Outcome Analysis
Their research addresses critical needs in managing treatment-resistant gastrointestinal cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.